Terms: = Lung cancer AND CYLD, CYLD1, 1540, ENSG00000083799, USPL2, KIAA0849, CYLDI, CDMT, HSPC057, FLJ31664, FLJ20180, EAC AND Prognosis
13 results:
1. Clinicopathological, metastatic and prognostic features of stage IV esophageal adenocarcinoma versus squamous cell carcinoma: a SEER database analysis.
Pan L; Zhang Y; Gao Y; Qiu J
Chin Clin Oncol; 2024 Feb; 13(1):2. PubMed ID: 38372056
[TBL] [Abstract] [Full Text] [Related]
2. A novel necroptosis related gene signature and regulatory network for overall survival prediction in lung adenocarcinoma.
Wang G; Liu X; Liu H; Zhang X; Shao Y; Jia X
Sci Rep; 2023 Sep; 13(1):15345. PubMed ID: 37714937
[TBL] [Abstract] [Full Text] [Related]
3. Development of a prognostic signature of patients with esophagus adenocarcinoma by using immune-related genes.
Zhang X; Yang L; Kong M; Ma J; Wei Y
BMC Bioinformatics; 2021 Nov; 22(1):536. PubMed ID: 34724890
[TBL] [Abstract] [Full Text] [Related]
4. STAT3/miR-135b/NF-κB axis confers aggressiveness and unfavorable prognosis in non-small-cell lung cancer.
Zhao J; Wang X; Mi Z; Jiang X; Sun L; Zheng B; Wang J; Meng M; Zhang L; Wang Z; Song J; Yuan Z; Wu Z
Cell Death Dis; 2021 May; 12(5):493. PubMed ID: 33990540
[TBL] [Abstract] [Full Text] [Related]
5. MiR-587 acts as an oncogene in non-small-cell lung carcinoma via reducing cyld expression.
Li XJ; Chen LW; Gao P; Jia YJ
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12741-12747. PubMed ID: 33378022
[TBL] [Abstract] [Full Text] [Related]
6. Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma.
Matsui D; Zaidi AH; Martin SA; Omstead AN; Kosovec JE; Huleihel L; Saldin LT; DiCarlo C; Silverman JF; Hoppo T; Finley GG; Badylak SF; Kelly RJ; Jobe BA
Oncotarget; 2016 Dec; 7(49):81281-81291. PubMed ID: 27793030
[TBL] [Abstract] [Full Text] [Related]
7. The lncRNA MALAT1 is a novel biomarker for gastric cancer metastasis.
Xia H; Chen Q; Chen Y; Ge X; Leng W; Tang Q; Ren M; Chen L; Yuan D; Zhang Y; Liu M; Gong Q; Bi F
Oncotarget; 2016 Aug; 7(35):56209-56218. PubMed ID: 27486823
[TBL] [Abstract] [Full Text] [Related]
8. Adenoid cystic carcinoma of the external auditory canal with metastases to lymph nodes and lungs--problematic diagnosis and treatment based on a case report.
Buda-Nowak A; Swiąder M; Püsküllüoğlu M; Dyduch G; Krupiński M; Krzemieniecki K
Przegl Lek; 2015; 72(7):383-6. PubMed ID: 26817353
[TBL] [Abstract] [Full Text] [Related]
9. A comparison of the proposed classifications for the revision of N descriptors for non-small-cell lung cancer.
Lee GD; Kim DK; Moon DH; Joo S; Hwang SK; Choi SH; Kim HR; Kim YH; Park SI
Eur J Cardiothorac Surg; 2016 Feb; 49(2):580-8. PubMed ID: 25890940
[TBL] [Abstract] [Full Text] [Related]
10. Spectrum of somatic EGFR, KRAS, BRAF, PTEN mutations and TTF-1 expression in Brazilian lung cancer patients.
Carneiro JG; Couto PG; Bastos-Rodrigues L; Bicalho MA; Vidigal PV; Vilhena A; Amaral NF; Bale AE; Friedman E; De Marco L
Genet Res (Camb); 2014; 96():e002. PubMed ID: 24594201
[TBL] [Abstract] [Full Text] [Related]
11. Classifications of n2 non-small-cell lung cancer based on the number and rate of metastatic mediastinal lymph nodes.
Ito M; Yamashita Y; Tsutani Y; Misumi K; Harada H; Miyata Y; Okada M
Clin Lung Cancer; 2013 Nov; 14(6):651-7. PubMed ID: 24188630
[TBL] [Abstract] [Full Text] [Related]
12. mRNA expression levels and genetic status of genes involved in the EGFR and NF-κB pathways in metastatic non-small-cell lung cancer patients.
Santarpia M; Magri I; Sanchez-Ronco M; Costa C; Molina-Vila MA; Gimenez-Capitan A; Bertran-Alamillo J; Mayo C; Benlloch S; Viteri S; Gasco A; Mederos N; Carcereny E; Taron M; Rosell R
J Transl Med; 2011 Sep; 9():163. PubMed ID: 21951562
[TBL] [Abstract] [Full Text] [Related]
13. Endoscopic therapy of Barrett's esophagus and esophageal adenocarcinoma.
Tantau M; Mosteanu O; Pop T; Tantau A; Mester G
J Gastrointestin Liver Dis; 2010 Jun; 19(2):213-7. PubMed ID: 20593060
[TBL] [Abstract] [Full Text] [Related]
